Anticoagulant drug monitoring

A growing menu of assays

There are an increasing number of direct oral anticoagulants (DOACs) and direct thrombin inhibitors (DTI) available on the market. With increasing clinical utilization, drug-level monitoring needs also have increased. Some DOACs and DTIs require routine monitoring, while others are monitored in more select clinical situations. Our Special Coagulation Laboratory offers clients access to a growing menu of special coagulation drug assays.